Skip to content

Clinical trials

Phase 3 Prostatic Neoplasms trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 3 Country / region: Russia Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20051
20063
20074
20083
20094
20102
20115
20123
20133
20143
20152
20161
20171
20194
20205
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Active, not recruiting10
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi5
Aragon Pharmaceuticals, Inc.4
AstraZeneca4
Ferring Pharmaceuticals4
Janssen Research & Development, LLC4
Bayer3
Bristol-Myers Squibb3
Merck Sharp & Dohme LLC3
Pfizer3
Amgen2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms52
Neoplasm Metastasis4
Neoplasms4
Bone Diseases, Metabolic1
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Ovarian Epithelial1
Cataract1
Fallopian Tube Neoplasms1
Genital Neoplasms, Male1

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.